Precigen, Inc. (PGEN) Builds Commercial Stage With Global Regulatory Support
Precigen Inc. (NASDAQ:PGEN) is one of Goldman Sachs’ top penny stock picks. On January 20, Precigen Inc.
Precigen Inc. (PGEN)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Patient Capital Management Samantha Mclemore | 18,673,466 | $78,055,089 | -30% | 3.01% |
| 2. | Diametric Capital Nick Thakore | 3,847,024 | $16,080,560 | +295% | 4.31% |
| 3. | Iridian Asset Management David Cohen And Harold Levy | 3,600,195 | $15,048,815 | -2% | 5.54% |
| 4. | Impala Asset Management Robert Bishop | 165,000 | $689,700 | 0.43% | |
| 5. | 100,000 | $418,000 | 0.2% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.40 | 2,000 | $6,800.00 | 405,959 | 2025-09-26 | Filing | |
| $3.58 | 6,000 | $21,480.00 | 65,031 | 2025-09-29 | Filing | |
| $3.42 | 2,932 | $10,027.44 | 468,626 | 2025-09-26 | Filing | |
| $3.62 | 8,284 | $29,988.08 | 465,694 | 2025-09-25 | Filing | |
| $4.60 | 15,000 | $69,000.00 | 217,841 | 2025-09-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.18 | 956,200 | $3,996,916.00 | 4,598,044 | 2025-12-22 | Filing | |
| $4.18 | 5,958 | $24,904.44 | 447,773 | 2025-12-22 | Filing | |
| $4.18 | 9,931 | $41,511.58 | 341,189 | 2025-12-22 | Filing | |
| $4.18 | 11,917 | $49,813.06 | 566,162 | 2025-12-22 | Filing | |
| $4.18 | 42,702 | $178,494.36 | 1,594,338 | 2025-12-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 15,094,359 | $63,094,420 | 0% | |
| 2. | 10,824,860 | $45,247,915 | 0% | |
| 3. | 10,479,452 | $43,804,109 | 0% | |
| 4. | 4,462,078 | $18,653,479 | 0% | |
| 5. | 3,501,739 | $14,637,269 | 10.16% |
News See All
Goldman Sachs Penny Stocks: Top 12 Stock Picks
The rotation towards small and micro-cap stocks is gaining momentum.
Precigen, Inc. (NASDAQ:PGEN) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Precigen Third Quarter 2025 Financial Results and Business Updates Conference Call. At this time, all lines are in listen-only mode.
Precigen Reports Positive Long-Term Follow-Up Data for FDA-Approved RRP Therapy, PAPZIMEOS
Precigen Inc. (NASDAQ:PGEN) is one of the hot stocks to buy with huge upside potential.
12 Hot Stocks to Buy with Huge Upside Potential
On October 22, Vios Advisors’ Michael Bapis and BNY’s Alicia Levine joined CNBC's 'Closing Bell' to discuss the latest news affecting markets.
Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization
Precigen, Inc. (NASDAQ:PGEN) is a biotechnology company developing precision genetic medicines for oncology, infectious diseases, and rare conditions.
15 Best Biotech Penny Stocks to Invest in Right Now
Jared Holz, the healthcare strategist for Mizuho, spoke on CNBC's "Closing Bell Overtime" in July on whether the biotech industry is ready for a breakthrough.
Precigen, Inc. (PGEN) Bolsters Financial Standing to Enhance PAPZIMEOS Commercialization
Precigen, Inc. (NASDAQ:PGEN) is one of the best healthcare penny stocks to buy now.
11 Best Healthcare Penny Stocks to Buy Now
The US healthcare sector is one of the biggest in the world, with spending expected to reach $5.3 trillion this year.
Precigen Signs a Credit Facility Agreement Worth $125 Million to Support PAPZIMEOS
Precigen, Inc. (NASDAQ:PGEN) is one of the 12 Best NASDAQ Penny Stocks to Buy According to Hedge Funds. On September 3, Precigen, Inc.
Hedge Fund Resource Center Billionaire Hedge Funds
